Targeting γ-secretase in breast cancer

References

• McCarthyJVTwomeyCWujekPPresenilin-dependent regulated intramembrane proteolysis and gamma-secretase activityCell Mol Life Sci20096691534155519189053
   PubMed Web of Science ®Google Scholar
• De StrooperBAnnaertWNovel research horizons for presenilins and γ-secretases in cell biology and diseaseAnnu Rev Cell Dev Biol20102623526020604710
   PubMed Web of Science ®Google Scholar
• JorissenEDe StrooperBGamma-secretase and the intramembrane proteolysis of NotchCurr Top Dev Biol20109220123020816396
   PubMed Web of Science ®Google Scholar
• GuYChenFSanjoNAPH-1 interacts with mature and immature forms of presenilins and nicastrin and may play a role in maturation of presenilin, nicastrin complexesJ Biol Chem200327897374738012471034
   PubMed Web of Science ®Google Scholar
• LaiMTChenECrouthamelMCPresenilin-1 and presenilin-2 exhibit distinct yet overlapping gamma-secretase activitiesJ Biol Chem200327825224752248112684521
   PubMed Web of Science ®Google Scholar
• SerneelsLVan BiervlietJCraessaertsKGamma-secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer’s diseaseScience2009324592763964219299585
   PubMed Web of Science ®Google Scholar
• ShahSLeeSFTabuchiKNicastrin functions as a gamma-secretase-substrate receptorCell2005122343544716096062
   PubMed Web of Science ®Google Scholar
• ZhaoGLiuZIlaganMXKopanRGamma-secretase composed of PS1/Pen2/Aph1a can cleave notch and amyloid precursor protein in the absence of nicastrinJ Neurosci20103051648165620130175
   PubMed Web of Science ®Google Scholar
• TakasugiNTomitaTHayashiIThe role of presenilin cofactors in the gamma-secretase complexNature2003422693043844112660785
   PubMed Web of Science ®Google Scholar
• ChenACGuoLYOstaszewskiBLSelkoeDJLaVoieMJAph-1 associates directly with full-length and C-terminal fragments of gamma-secretase substratesJ Biol Chem201028515113781139120145246
   PubMed Web of Science ®Google Scholar
• HaassCSteinerHAlzheimer disease gamma-secretase: a complex story of GxGD-type presenilin proteasesTrends Cell Biol2002121255656212495843
   PubMed Web of Science ®Google Scholar
• OlsonREAlbrightCFRecent progress in the medicinal chemistry of gamma-secretase inhibitorsCurr Top Med Chem200881173318220929
   PubMed Web of Science ®Google Scholar
• KreftAFMartoneRPorteARecent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer’s diseaseJ Med Chem200952206169618819694467
   PubMed Web of Science ®Google Scholar
• ShearmanMSBeherDClarkeEEL-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activityBiochemistry200039308698870410913280
   PubMed Web of Science ®Google Scholar
• ClarkeEEChurcherIEllisSIntra- or intercomplex binding to the gamma-secretase enzyme. A model to differentiate inhibitor classesJ Biol Chem200628142312793128916899457
   PubMed Web of Science ®Google Scholar
• DoveyHFJohnVAndersonJPFunctional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brainJ Neurochem200176117318111145990
   PubMed Web of Science ®Google Scholar
• SeiffertDBradleyJDRomingerCMPresenilin-1 and -2 are molecular targets for gamma-secretase inhibitorsJ Biol Chem200027544340863409110915801
   PubMed Web of Science ®Google Scholar
• WongGTManfraDPouletFMChronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiationJ Biol Chem200427913128761288214709552
   PubMed Web of Science ®Google Scholar
• LewisHDPerez RevueltaBINadinACatalytic site-directed gamma-secretase complex inhibitors do not discriminate pharmacologically between Notch S3 and beta-APP cleavagesBiochemistry200342247580758612809514
   PubMed Web of Science ®Google Scholar
• LanzTAHosleyJDAdamsWJMerchantKMStudies of Abeta pharmacodynamics in the brain, cerebrospinal fluid, and plasma in young (plaque-free) Tg2576 mice using the gamma-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-di hydro-5H-dibenzo[b,d]azepin-7-yl]-L-alanin-amide (LY-411575)J Pharmacol Exp Ther20043091495514718585
   PubMed Web of Science ®Google Scholar
• HydeLAMcHughNAChenJStudies to investigate the in vivo therapeutic window of the gamma-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-di hydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY411,575) in the CRND8 mouseJ Pharmacol Exp Ther200631931133114316946102
   PubMed Web of Science ®Google Scholar
• SiemersESkinnerMDeanRASafety, tolerability, and changes in amyloid beta concentrations after administration of a gamma-secretase inhibitor in volunteersClin Neuropharmacol200528312613215965311
   PubMed Web of Science ®Google Scholar
• HenleyDBMayPCDeanRASiemersERDevelopment of semagacestat (LY450139), a functional gamma-secretase inhibitor, for the treatment of Alzheimer’s diseaseExpert Opin Pharmacother200910101657166419527190
   PubMed Web of Science ®Google Scholar
• LuistroLHeWSmithMPreclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic propertiesCancer Res200969197672768019773430
   PubMed Web of Science ®Google Scholar
• HanJMaIHendzelMJAllalunis-TurnerJThe cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibitionBreast Cancer Res2009114R5719660128
   PubMed Web of Science ®Google Scholar
• WeihofenALembergMKFriedmannETargeting presenilin-type aspartic protease signal peptide peptidase with gamma-secretase inhibitorsJ Biol Chem200327819165281653312621027
   PubMed Web of Science ®Google Scholar
• GoldeTEWolfeMSGreenbaumDCSignal peptide peptidases: a family of intramembrane-cleaving proteases that cleave type 2 trans-membrane proteinsSemin Cell Dev Biol200920222523019429495
   PubMed Web of Science ®Google Scholar
• YanDQinNZhangHExpression of TNF-alpha leader sequence renders MCF-7 tumor cells resistant to the cytotoxicity of soluble TNF-alphaBreast Cancer Res Treat200911619110218618239
   PubMed Web of Science ®Google Scholar
• DongYLiAWangJWeberJDMichelLSSynthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancerCancer Res201070135465547420570903
   PubMed Web of Science ®Google Scholar
• FilipovicAGronauJHGreenARBiological and clinical implications of nicastrin expression in invasive breast cancerBreast Cancer Res Treat20111251435320224929
   PubMed Web of Science ®Google Scholar
• KopanRIlaganMXThe canonical Notch signaling pathway: unfolding the activation mechanismCell2009137221623319379690
   PubMed Web of Science ®Google Scholar
• HeitzlerPBiodiversity and noncanonical Notch signalingCurr Top Dev Biol20109245748120816404
   PubMed Web of Science ®Google Scholar
• Al-HussainiHSubramanyamDReedijkMSridharSSNotch signaling pathway as a therapeutic target in breast cancerMol Cancer Ther201110191520971825
   PubMed Web of Science ®Google Scholar
• RizzoPOsipoCForemanKGoldeTOsborneBMieleLRational targeting of Notch signaling in cancerOncogene200827385124513118758481
   PubMed Web of Science ®Google Scholar
• ShiWHarrisALNotch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentialsJ Mammary Gland Biol Neoplasia2006111415216947085
   PubMed Web of Science ®Google Scholar
• HarrisonHFarnieGBrennanKRClarkeRBBreast cancer stem cells: something out of notching?Cancer Res201070228973897621045140
   PubMed Web of Science ®Google Scholar
• HanJHendzelMJAllalunis-TurnerJNotch signaling as a therapeutic target for breast cancer treatment?Breast Cancer Res201113321021672271
   PubMed Web of Science ®Google Scholar
• RobinsonDRKalyana-SundaramSWuYMFunctionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancerNat Med201117121646165122101766
   PubMed Web of Science ®Google Scholar
• RidgwayJZhangGWuYInhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesisNature200644471221083108717183323
   PubMed Web of Science ®Google Scholar
• Noguera-TroiseIDalyCPapadopoulosNJBlockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesisNature200644471221032103717183313
   PubMed Web of Science ®Google Scholar
• SethiNDaiXWinterCGKangYTumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cellsCancer Cell201119219220521295524
   PubMed Web of Science ®Google Scholar
• XingFOkudaHWatabeMHypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cellsOncogene201130394075408621499308
   PubMed Web of Science ®Google Scholar
• SundvallMIljinKKilpinenSSaraHKallioniemiOPEleniusKRole of ErbB4 in breast cancerJ Mammary Gland Biol Neoplasia200813225926818454307
   PubMed Web of Science ®Google Scholar
• ChuuCPChenRYBarkingeJLCiaccioMFJonesRBSystems-level analysis of ErbB4 signaling in breast cancer: a laboratory to clinical perspectiveMol Cancer Res20086688589118567793
   PubMed Web of Science ®Google Scholar
• SartorCIZhouHKozlowskaEHer4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cellsMol Cell Biol200121134265427511390655
   PubMed Web of Science ®Google Scholar
• NiCYMurphyMPGoldeTECarpenterGGamma-secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinaseScience200129455492179218111679632
   PubMed Web of Science ®Google Scholar
• VidalGANareshAMarreroLJonesFEPresenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activitiesJ Biol Chem200528020197771978315746097
   PubMed Web of Science ®Google Scholar
• FengSMSartorCIHunterDThe HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferationMol Endocrinol20072181861187617505063
   PubMedGoogle Scholar
• MarambaudPShioiJSerbanGA presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctionsEMBO J20022181948195611953314
   PubMed Web of Science ®Google Scholar
• BerxGVan RoyFThe E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progressionBreast Cancer Res20013528929311597316
   PubMed Web of Science ®Google Scholar
• FerberECKajitaMWadlowAA role for the cleaved cytoplasmic domain of E-cadherin in the nucleusJ Biol Chem200828319126911270018356166
   PubMed Web of Science ®Google Scholar
• ParkCSKimOSYunSMJoSAJoIKohYHPresenilin 1/gamma-secretase is associated with cadmium-induced E-cadherin cleavage and COX-2 gene expression in T47D breast cancer cellsToxicol Sci2008106241342218791180
   PubMed Web of Science ®Google Scholar
• LammichSOkochiMTakedaMPresenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptideJ Biol Chem200227747447544475912223485
   PubMed Web of Science ®Google Scholar
• MurakamiDOkamotoINaganoOPresenilin-dependent gamma-secretase activity mediates the intramembranous cleavage of CD44Oncogene200322101511151612629514
   PubMed Web of Science ®Google Scholar
• MarhabaRZollerMCD44 in cancer progression: adhesion, migration and growth regulationJ Mol Histol200435321123115339042
   PubMed Web of Science ®Google Scholar
• LouderboughJMSchroederJAUnderstanding the dual nature of CD44 in breast cancer progressionMol Cancer Res20119121573158621970856
   PubMed Web of Science ®Google Scholar
• OkamotoIKawanoYMurakamiDProteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathwayJ Cell Biol2001155575576211714729
   PubMed Web of Science ®Google Scholar
• PelletierLGuillaumotPFrecheBGamma-secretase-dependent proteolysis of CD44 promotes neoplastic transformation of rat fibroblastic cellsCancer Res20066673681368716585194
   PubMed Web of Science ®Google Scholar
• De FalcoVTamburrinoAVentreSCD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cellsCancer Res20127261449145822271686
   PubMed Web of Science ®Google Scholar
• ZhangYWWangRLiuQZhangHLiaoFFXuHPresenilin/gamma-secretase-dependent processing of beta-amyloid precursor protein regulates EGF receptor expressionProc Natl Acad Sci U S A200710425106131061817556541
   PubMed Web of Science ®Google Scholar
• LiuCXRanganathanSRobinsonSStricklandDKGamma-secretase-mediated release of the low density lipoprotein receptor-related protein 1B intracellular domain suppresses anchorage-independent growth of neuroglioma cellsJ Biol Chem2007282107504751117227771
   PubMed Web of Science ®Google Scholar
• KimDYInganoLACareyBWPettingellWHKovacsDMPresenilin/gamma-secretase-mediated cleavage of the voltage-gated sodium channel beta2-subunit regulates cell adhesion and migrationJ Biol Chem200528024232512326115833746
   PubMed Web of Science ®Google Scholar
• YamaguchiNOyamaTItoENOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cellsCancer Res20086861881188818339869
   PubMed Web of Science ®Google Scholar
• RizzoPMiaoHD’SouzaGCross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approachesCancer Res200868135226523518593923
   PubMed Web of Science ®Google Scholar
• OsipoCPatelPRizzoPErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitorOncogene200827375019503218469855
   PubMed Web of Science ®Google Scholar
• YongTSunAHenryMDMeyersSDavisJNDown regulation of CSL activity inhibits cell proliferation in prostate and breast cancer cellsJ Cell Biochem201111292340235121520243
   PubMed Web of Science ®Google Scholar
• JacksonALBartzSRSchelterJExpression profiling reveals off-target gene regulation by RNAiNat Biotechnol200321663563712754523
   PubMed Web of Science ®Google Scholar
• ScacheriPCRozenblatt-RosenOCaplenNJShort interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cellsProc Natl Acad Sci U S A200410171892189714769924
   PubMed Web of Science ®Google Scholar
• van EsJHvan GijnMERiccioONotch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cellsNature2005435704495996315959515
   PubMed Web of Science ®Google Scholar
• FleisherASRamanRSiemersERPhase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer diseaseArch Neurol20086581031103818695053
   PubMedGoogle Scholar
• TammamJWareCEffersonCDown-regulation of the Notch pathway mediated by a gamma-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemiaBr J Pharmacol200915851183119519775282
   PubMed Web of Science ®Google Scholar
• RealPJToselloVPalomeroTGamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemiaNat Med2009151505819098907
   PubMed Web of Science ®Google Scholar
• RadtkeFFasnachtNMacdonaldHRNotch signaling in the immune systemImmunity2010321142720152168
   PubMed Web of Science ®Google Scholar
• DouGRWangYCHuXBRBP-J, the transcription factor downstream of Notch receptors, is essential for the maintenance of vascular homeostasis in adult miceFASEB J20082251606161718096813
   PubMed Web of Science ®Google Scholar
• Ya nMCallahanCABeyerJCChronic DLL4 blockade induces vascular neoplasmsNature20104637282E6E720147986
   PubMed Web of Science ®Google Scholar
• LiuZTurkozAJacksonENNotch1 loss of heterozygosity causes vascular tumors and lethal hemorrhage in miceJ Clin Invest2011121280080821266774
   PubMed Web of Science ®Google Scholar
• DemehriSTurkozAKopanREpidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironmentCancer Cell2009161556619573812
   PubMed Web of Science ®Google Scholar
• NicolasMWolferARajKNotch1 functions as a tumor suppressor in mouse skinNat Genet200333341642112590261
   PubMed Web of Science ®Google Scholar
• ExtanceAAlzheimer’s failure raises questions about disease-modifying strategiesNat Rev Drug Discov201091074975120885394
   PubMed Web of Science ®Google Scholar
• WangNJSanbornZArnettKLLoss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinomaProc Natl Acad Sci U S A201110843177611776622006338
   PubMed Web of Science ®Google Scholar
• KondratyevMKresoAHallettRMGamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancerOncogene20123119310321666715
   PubMed Web of Science ®Google Scholar
• EffersonCLWinkelmannCTWareCDownregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer modelCancer Res20107062476248420197467
   PubMed Web of Science ®Google Scholar
• WattersJWChengCMajumderPKDe novo discovery of a gamma-secretase inhibitor response signature using a novel in vivo breast tumor modelCancer Res200969238949895719903844
   PubMed Web of Science ®Google Scholar